BAYER DIAGNOSTICS ACS:180 VB12, BAYER DIAGNOSTICS ADVIA CENTAUE VB12— 510(k) K993571

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K993571 for BAYER DIAGNOSTICS ACS:180 VB12, BAYER DIAGNOSTICS ADVIA CENTAUE VB12, Substantially Equivalent on 1999-12-16. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code CDD
Advisory panel: Clinical Chemistry
Date received: 1999-10-21
Decision date: 1999-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.